Constellation Energy Corporation

Constellation Energy is the largest U.S.
CEG  ยท Utilities ยท Independent Power Producers  ยท Market cap $94.12B
QuantHub Original Research ยท Updated 2026-09-22  ยท 
High Quality A-tier business, C-tier valuation: 4.2% downside to $250.98 fair value despite a Strong Buy consensus and 40.8% upside to the $369 target. Fair Value
--
QHQuantHub Fair Value: $250.98  ยท  -4.7% downside How we research this โ†—
Buy Zone: $188.23 โ€“ $213.33
Updated 4 days ago
Want CEG in your morning briefing? Sign up free โ†’
CEG is trading near fair value. No urgent action needed.
QuantHub Research: Investment Thesis
Investing Phase
Constellation Energy is the largest U.S. producer of carbon-free electricity, operating roughly 32,400 megawatts of nuclear, gas, wind, solar, and hydro generation across the Mid-Atlantic, Midwest, New York, ERCOT, and other power markets, with a 94.9% TTM gross margin that reflects the low marginal cost of nuclear fuel and the scarcity value of firm clean power. The business quality is genuinely high, but the stock is not cheap: at $262.11 the shares trade at 26.68 times trailing earnings, 13.88 times EV/EBITDA, and 300.28 times trailing free cash flow, with a $0.87 FCF per share against $87.08 of revenue per share, and the quantitative model puts fair value at $250.98, implying 4.2% downside to fair value, or a 4.4% premium to that estimate. Revenue grew 23.0% in the most recent quarter, but GAAP earnings fell 38.9% year over year as Q2 net interest expense jumped to $283 million from $118 million and integration costs reached $87 million, the visible cost of the Calpine acquisition and the $19.606 billion of long-term debt plus $5.226 billion of short-term borrowings on the balance sheet. The bull case rests on contracted nuclear demand, the Crane restart, and a 920 MW PPA pipeline beginning in 2029; the bear case rests on PJM capacity collars capping scarcity upside, weak free cash flow conversion, and a valuation regime the model flags as expensive versus five-year history. Analyst consensus is a Strong Buy with a $369 average target, 40.8% above the current price, so the market is clearly pricing a much better outcome than the blended fair value estimate implies.
The shares are expensive on the model's historical-multiple lens, with a valuation regime flagged as expensive and fair value of $250.98 sitting 4.2% below the $262.11 price, a 4.4% premium to that estimate. The market is paying 26.68 times trailing earnings and 300.28 times trailing free cash flow for a business whose GAAP earnings fell 38.9% year over year in the most recent quarter, and 13.88 times EV/EBITDA leaves little room for the integration and interest costs tied to Calpine to surprise to the downside. The gap between the blended fair value and the $369 analyst target, 40.8% above the current price, shows the sell side is capitalizing the nuclear-contracting and Crane-restart narrative well before the cash flows arrive, while the quantitative model is anchored on current earnings and free cash flow. That is the mispricing: the stock is not cheap versus its own history, but it is priced for a future that has not yet been delivered.
12โ€“18 Month Outlook
Over the next 18 months Constellation faces a tug-of-war between contracted growth and near-term earnings pressure. Revenue grew 23.0% in the most recent quarter, but GAAP earnings fell 38.9% year over year, and the Calpine-related interest burden of $283 million in Q2 net interest expense will keep reported earnings volatile. The Crane restart remains a late-2027 event with the final environmental assessment expected around September 2026, so it will not contribute to 2026 or most of 2027 results, and the 920 MW PPA commencements do not begin until 2029. With fair value at $250.98, 4.2% below the current $262.11 price, the shares carry a 4.4% premium to that estimate, and the model's expensive valuation regime means multiple compression is a real risk if free cash flow of $0.87 per share does not improve. The analyst target of $369 implies 40.8% upside, so the stock is likely to trade on contract announcements and NRC milestones rather than near-term GAAP earnings.
Bull vs Bear

Bull Case

  • Constellation is the largest U.S. producer of clean, reliable power with roughly 32,400 megawatts of generation, and its 94.9% TTM gross margin shows the structural cost advantage of a nuclear-heavy fleet.
  • Revenue grew 23.0% in the most recent quarter, and management raised 2026 adjusted operating EPS guidance to $11.50 to $12.50, indicating confidence in the underlying earnings power.
  • The 920 MW of recently announced 15- to 20-year nuclear PPAs beginning in 2029 provide long-duration contracted demand validation for carbon-free baseload power.
  • The Crane Clean Energy Center restart targets late 2027 and would add a prominent source of carbon-free supply, with the final environmental assessment expected around September 2026.
  • Analyst consensus is a Strong Buy with a $369 average target, 40.8% above the current $262.11 price, suggesting the sell side sees substantial value in the contracted nuclear pipeline.

Bear Case

  • FERC accepted a roughly $175 to $325 per MW-day collar for the 2028/2029 and 2029/2030 PJM capacity auctions, and all submitted CEG units cleared the July 2026 auction at the $325 cap, limiting further scarcity-driven upside for those delivery years.
  • At June 30, 2026, CEG carried $19.606 billion of long-term debt including current maturities and $5.226 billion of short-term borrowings, while Q2 net interest expense rose to $283 million from $118 million a year earlier and integration costs were $87 million in Q2 and $211 million in the first half.
  • Free cash flow is thin relative to the equity value, with $0.87 of FCF per share against $87.08 of revenue per share and a P/FCF of 300.28, leaving the shares vulnerable to multiple compression if capex and integration spending stay elevated.
  • GAAP earnings fell 38.9% year over year in the most recent quarter, and the company has shown sharp sentiment reactions to results and outlook changes, heightening sensitivity to hedging, financing, and adjustment items.
  • Nuclear output declined to 44,160 GWh in Q2 2026 from 45,170 GWh a year earlier, and capacity factor excluding Salem and STP fell to 93.0% from 94.8%, so outages or refueling underperformance would directly hit merchant generation earnings.
Leadership & Competitive Position

Joseph Dominguez

  • Tenure4 yrs
  • Beats guidance75% of qtrs
  • Capital allocationFair

Joseph Dominguez has led Constellation since its 2022 spin-off from Exelon, building the company into the largest U.S. clean-energy producer and executing the Calpine acquisition. The strategic logic of consolidating dispatchable and nuclear generation is sound, but the balance sheet now carries $19.606 billion of long-term debt including current maturities and $5.226 billion of short-term borrowings, and Q2 net interest expense more than doubled to $283 million from $118 million, so capital allocation deserves scrutiny until free cash flow improves from $0.87 per share.

Competitive Moat stable

cost advantageintangible assets

Constellation describes itself as the nation's largest producer of reliable and clean energy, with roughly 32,400 megawatts of generation across the Mid-Atlantic, Midwest, New York, ERCOT, and other power markets. Its nuclear fleet is the core asset, and the 94.9% TTM gross margin reflects the low marginal cost of nuclear fuel relative to fossil generation.

Competitors: Vistra (VST), NRG Energy (NRG), Public Service Enterprise Group (PEG)

Disruption: Low. Nuclear baseload generation is difficult to replicate at scale, and the 920 MW of 15- to 20-year PPAs beginning in 2029 show customers are willing to contract for carbon-free firm power. The main disruption risk is regulatory or market-design change, not technological substitution.

QuantHub Research

Valuation
MultipleCurrentMedian 3yrMedian 5yrMin 5yrMax 5yr
P/E 26.68x23.28x23.28x18.8x47.74x
P/S 3.01x2.99x1.52x0.7x4.33x
P/FCF300.28x85.85x85.85x85.85x85.85x
P/S 3.01x vs 5yr range 0.7-4.33x (P25=0.7x, median=1.52x, P75=2.99x)

Price Outlook (5-Year)

Bear
$201
-5.3%/yr
Base
$251
-1.0%/yr
fair value
Bull
$301
2.7%/yr

Bear/Base/Bull anchored to QuantHub fair value estimate. Base = headline fair value; Bear −20%; Bull +20%.

DCF: $14.48  ยท 0.11 discount rate  ยท 11.0x terminal multiple  ยท Blended methodology โ€” DCF models cash flows; fair value blends DCF with comparables multiples.
Key Metrics
Revenue Growth
23.0%
Gross Margin
94.9%
ROE
14.7%
FCF Yield
0.33%
Debt/Equity
0.77x
P/E Trailing
26.68x
P/S
3.01x
P/FCF
300.28x
EV/EBITDA
13.88x
Op. Margin
14.7%
Dividend Yield
0.64%
Price Context
Trend
Below 200-day average
Price Strength (14-day)
40.6 mid-range
Recent low
$251.33
Recent high
$284.25
Risks
PJM capacity-market price caps
high
FERC accepted a roughly $175 to $325 per MW-day collar for the 2028/2029 and 2029/2030 PJM capacity auctions. All submitted CEG units cleared the July 2026 auction at the $325 per MW-day cap, limiting further scarcity-driven upside for those delivery years.
Calpine leverage and integration
high
At June 30, 2026, CEG had $19.606 billion of long-term debt including current maturities and $5.226 billion of short-term borrowings. Q2 net interest expense rose to $283 million from $118 million a year earlier, while integration costs were $87 million in Q2 and $211 million in the first half.
Crane restart execution
medium
The Crane restart still requires final NRC approval, with the final environmental assessment expected around September 2026 and targeted restart not until late 2027. Regulatory delay, cost escalation, or operational issues would postpone a key clean-power growth catalyst.
Nuclear reliability and safety
medium
Nuclear output declined to 44,160 GWh in Q2 2026 from 45,170 GWh a year earlier, and capacity factor excluding Salem and STP fell to 93.0% from 94.8%. Outages, refueling performance, safety events, or regulatory constraints can materially affect merchant generation earnings.
Rich valuation and weak free cash flow
medium
CEG trades at 26.68 times trailing earnings, 13.88 times EV/EBITDA, and 300.28 times trailing free cash flow, while fair value is estimated at $250.98 versus a $262.11 share price, a 4.4% premium to that estimate. Heavy capex and integration spending leave the shares vulnerable to multiple compression.
Guidance credibility and EPS volatility
low
Despite raising 2026 adjusted operating EPS guidance to $11.50 to $12.50, the company has experienced sharp sentiment reactions to results and outlook changes. The 38.9% year-over-year decline in GAAP EPS in the most recent quarter heightens sensitivity to hedging, financing, and adjustment items.
Growth Engines
Nuclear PPA contracting early
The first of 920 MW of recently announced 15- to 20-year nuclear PPAs begins in 2029, providing long-duration contracted demand for carbon-free baseload power.
Crane nuclear restart early
The Crane Clean Energy Center targets a late-2027 restart subject to final NRC approval, adding a prominent source of carbon-free supply to the fleet.
Calpine integration synergies scaling
The Calpine combination expands the generation and retail platform, though integration costs were $87 million in Q2 and $211 million in the first half of 2026.
Uranium supply ventures early
Constellation Technology Ventures participated in Fluxnium's $7 million seed round for seawater-adsorbed uranium, an early-stage option on domestic fuel supply.
Recent Developments
2026-09-21
Constellation shares close at $262.11, up 2.91%
The most recent trading session saw a 2.91% gain to $262.11, leaving the shares 4.2% above the $250.98 fair value estimate and 40.8% below the $369 analyst target.
2026-09-21
Constellation Technology Ventures backs Fluxnium seed round
Constellation's venture arm participated in a $7 million seed round for Fluxnium, which is developing seawater-adsorbed uranium, an early-stage option on domestic nuclear fuel supply.
2026-09-20
Investor commentary emphasizes nuclear fleet over AI headlines
Published analysis argues the investment case rests on the nuclear fleet rather than AI-driven demand headlines, a reminder that the stock trades on long-duration contracted power rather than near-term data-center speculation.
More Research

Original research. Not scraped from Wall Street.

This is AI-powered fundamental analysis built from scratch โ€” not aggregated analyst ratings. Get this research for your entire portfolio plus daily briefings, research signals, and options income.

Get your portfolio research โ†’ Free to start

How QuantHub Researches Stocks

QuantHub research is focused on quality businesses with durable competitive advantages โ€” companies we'd want to own for 3โ€“5 years or more. We are not short-term traders. Every analysis is built around a single question: is this a great business available at a reasonable price for a long-term investor?

We start where most analysts finish: the fundamentals. For every company, our AI ingests years of financial statements โ€” revenue, margins, free cash flow, and how the business has been valued by the market across multiple cycles. But numbers alone don't tell you whether a business is worth owning.

The harder work is qualitative. We assess the competitive moat: is it widening or eroding? We read the leadership track record โ€” how capital has been allocated, whether management has earned trust through consistent execution. We look at what the market is afraid of, and whether that fear is priced in fairly or irrationally.

Valuation is always relative. A stock is cheap or expensive compared to its own history. We build scenario matrices anchored to 5-year historical multiples, then ask: what has to go right for the upside case, and what's the floor if it doesn't?

Finally, we write an 18-month forward outlook โ€” not a price target, but a mental model of where this business will be and what the narrative will look like. Every note is dated and versioned. When material facts change, we update the thesis.

Frequently Asked Questions

Is CEG undervalued?

CEG is currently fairly valued at $263.27 vs. our fair value estimate of $250.98 (-5% upside).

What is CEG's fair value?

QuantHub Research estimates CEG's fair value at $250.98 based on our proprietary valuation model incorporating historical P/S, P/E, and P/FCF multiples over a 5-year range.

What are the key risks for CEG?

PJM capacity-market price caps: FERC accepted a roughly $175 to $325 per MW-day collar for the 2028/2029 and 2029/2030 PJM capacity auctions. All submitted CEG units cleared the July 2026 auction at the $325 per MW-day cap, limiting further scarcity-driven upside for those delivery years. Calpine leverage and integration: At June 30, 2026, CEG had $19.606 billion of long-term debt including current maturities and $5.226 billion of short-term borrowings. Q2 net interest expense rose to $283 million from $118 million a year earlier, while integration costs were $87 million in Q2 and $211 million in the first half. Crane restart execution: The Crane restart still requires final NRC approval, with the final environmental assessment expected around September 2026 and targeted restart not until late 2027. Regulatory delay, cost escalation, or operational issues would postpone a key clean-power growth catalyst.

What is the bull case for CEG?

Constellation is the largest U.S. producer of clean, reliable power with roughly 32,400 megawatts of generation, and its 94.9% TTM gross margin shows the structural cost advantage of a nuclear-heavy fleet. Revenue grew 23.0% in the most recent quarter, and management raised 2026 adjusted operating EPS guidance to $11.50 to $12.50, indicating confidence in the underlying earnings power. The 920 MW of recently announced 15- to 20-year nuclear PPAs beginning in 2029 provide long-duration contracted

How confident is QuantHub in CEG?

QuantHub has moderate conviction in CEG. Research last updated 2026-09-22.